Clinical trial · Interventional
Effect of Patient Position on Computerized Tomography Guided Celiac Trunk Neurolysis
Efficacy of Patient Position After Computerized Tomography Guided Antero-crural Celiac Trunk Neurolysis on Upper Abdominal Malignancy Pain
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Computerized tomography-guided Celiac plexus neurolysis has become a popular technique. As, it has Cross-section imaging system to avoids anatomic structures injury, it has high density resolution that clearly display the retro-peritoneal anatomic structures ,it allow an optimal puncture site selection and measured the angle and depth of the needle insertion accurately with display the range of the neurolytic agent diffusion
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Upper Abdominal Malignancy | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Double needle celiac neurolysis (DNCN) | Device | — | UNRESOLVED |
| Single needle celiac neurolysis (SNCN) | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Double needle celiac neurolysis (DNCN)
- description
- Patients were subjected to CT guided celiac neurolysis using 2 needle antero-crural technique on each side with patient in prone position and both needles will be lateral to the aorta
- interventionNames
- Device: Double needle celiac neurolysis (DNCN)
- type
- PLACEBO_COMPARATOR
- label
- Single needle celiac neurolysis (SNCN)
- description
- Patients were subjected to CT guided celiac neurolysis using a single needle antero-crural approach from left side to be just in the front of the aorta near the origin of celiac trunk with patient in lateral position with his left side up then after the injection the patient were kept to his right side up for more homogenous spread of the dye.
- interventionNames
- Device: Single needle celiac neurolysis (SNCN)
Primary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with gastric carcinoma * Patients with hepato-biliary-pancreatic cancer * Patients with colonic malignancy * Patients with peritoneal metastasis * Patients with extensive hepatic metastasis * Patients having intractable pain to opioids and other analgesics. * Patients experienced adverse effects to opioids or other analgesics. * Patients experienced improved intractable pain after diagnostic celiac plexus block Exclusion Criteria: * Patient's refusal * Patients with bleeding tendency * Patients with coagulopathy * Patients who were benefited from oral analgesics with no serious side effects * Patients with significant cardiac diseases * Patients with organ failure * Patients with distant vertebral metastasis * Evidence of local infection at the puncture site * Patients who did not experience improved pain after receiving a diagnostic celiac plexus block
References
Publications (0)
Data not yet available